Funded Health Care Startups in Italy
Across 27 funded health care startups in Italy shown here (most recent 2025-05-13 through oldest 2021-03-10), disclosed round sizes cluster mostly in the l…
Across 27 funded health care startups in Italy shown here (most recent 2025-05-13 through oldest 2021-03-10), disclosed round sizes cluster mostly in the low single-digit millions, but Approxima’s $8M Series A (2025-02-20) stands out as the largest disclosed amount in the dataset, above the next-largest disclosed rounds such as SVAS Biosana’s $11M (2023-07-13) and Restorative Neurotechnologies’ $3M (2024-11-05). Disclosed amounts are also frequently small-to-mid: the smallest disclosed round is Oraltec’s $30K Pre-Seed (2024-09-09), while multiple pre-seed/seed deals sit in the ~$100K–$2M range (e.g., Holifya $530K on 2023-02-21; Soundsafe Care $2M on 2023-11-08).
City and stage concentration shows up in both timing and geography: Toscana appears with multiple entries (Relief in Pontedera on 2025-03-05; Oraltec and Soundsafe Care in Firenze/Pontedera in 2024–2023), while Milan/Lombardia recurs (Approxima $8M on 2025-02-20; Restorative Neurotechnologies $3M in Palermo is not Lombardy, but Milan-based Rosso $110K on 2024-09-01 and Euleria $400K are elsewhere; 1000Farmacie is explicitly Milan on 2022-02-07). The round records also show heavy classification gaps: 2 entries are marked undisclosed (Genius4U on 2025-05-13; BeForPharma on 2024-05-20) and an additional 1 entry is missing a stated series (Endostart on 2021-06-07).
Most recent rounds
27 shownRelated listings
Frequently asked
What’s the largest disclosed round among these Italy health care startups, and how distinct is it versus the rest?
The largest disclosed amount in the shown rows is SVAS Biosana’s $11M (2023-07-13). It’s notably above most other disclosed deals, including Approxima’s $8M (2025-02-20) and several rounds clustered around $1M–$6M such as Euleria Health’s $1M (2022-03-14) and Epicura’s $6M (2021-09-16).
Are there notable time clusters in the most recent entries (e.g., last 90 days from the newest round date)?
From the newest date (2025-05-13), four rounds fall within roughly the next 70 days: Medicud $650K (2025-04-10), Relief $1M (2025-03-05), Approxima $8M (2025-02-20), and Restorative Neurotechnologies $3M (2024-11-05 is outside that 90-day window).
Which cities or regions repeat often enough to suggest a local cluster in this list?
Toscana shows multiple appearances tied to Pontedera/Firenze/nearby areas, including Relief (Pontedera, 2025-03-05), Oraltec (Firenze, $30K on 2024-09-09), and Soundsafe Care (Pontedera, $2M on 2023-11-08). Lombardia also recurs via Approxima (Milan, $8M on 2025-02-20), Rosso (Milano, $110K on 2024-09-01), and 1000Farmacie (Milano, $15M on 2022-02-07).
How complete are the stage and amount disclosures, and does the classification pattern affect comparisons?
Three rows do not provide a usable disclosed amount/series for apples-to-apples sizing: Genius4U is undisclosed ($ undrawn) on 2025-05-13, BeForPharma is undisclosed on 2024-05-20, and Endostart lists an empty series with a disclosed $10M on 2021-06-07. The remaining rows provide disclosed amounts that enable size comparisons like Oraltec’s $30K (2024-09-09) versus SVAS Biosana’s $11M (2023-07-13).
Which stage mix dominates, based on the rounds shown, and are any stages especially concentrated near the larger checks?
Seed and pre-seed are frequent in the low-to-mid disclosed range (e.g., Rosso Seed $110K on 2024-09-01; Holifya Pre-Seed $530K on 2023-02-21; Soundsafe Care Pre-Seed $2M on 2023-11-08). Larger disclosed rounds skew toward later-stage labels among the stated ones, including Approxima’s Series A $8M (2025-02-20) and SVAS Biosana’s Series Unknown $11M (2023-07-13), rather than the smallest pre-seed entries such as Oraltec’s $30K.
Is there any clear outlier beyond size—such as a different category naming or unusually large/low checks?
Yes: Unobravo appears under a different naming label (“Telehealth & psychology platform”) while still categorized under Health Care, raising a category-boundary question versus the more typical “Health Care” labels (Unobravo Series A $17M on 2022-07-21). On size alone, Oraltec’s $30K (Pre-Seed on 2024-09-09) is the smallest disclosed check, while SVAS Biosana’s $11M (2023-07-13) is the largest disclosed amount, spanning the widest range in disclosed figures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.